GLP-1 medications and the shift toward flexible coverage models

Interest in GLP-1 medications continues to grow as coverage policies and out-of-pocket costs shift. Employees are weighing affordability, long-term access, and the role these medications play in their overall health journey. These findings highlight how GLP-1 use is influencing expectations around weight management and metabolic health support. This report offers practical perspective for employers navigating medication coverage while reinforcing the role of sustainable behavior change.

Share this:

Related Content